[go: up one dir, main page]

KE3860A - Devices for administering medicaments to patients - Google Patents

Devices for administering medicaments to patients

Info

Publication number
KE3860A
KE3860A KE3860A KE386089A KE3860A KE 3860 A KE3860 A KE 3860A KE 3860 A KE3860 A KE 3860A KE 386089 A KE386089 A KE 386089A KE 3860 A KE3860 A KE 3860A
Authority
KE
Kenya
Prior art keywords
patients
devices
administering medicaments
medicaments
administering
Prior art date
Application number
KE3860A
Other languages
English (en)
Inventor
Edward Newell Robert
Alexander Fitzsimmons Robert
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838314307A external-priority patent/GB8314307D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of KE3860A publication Critical patent/KE3860A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M13/00—Insufflators for therapeutic or disinfectant purposes, i.e. devices for blowing a gas, powder or vapour into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0003—Details of inhalators; Constructional features thereof with means for dispensing more than one drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A61M15/0035—Piercing means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/60—General characteristics of the apparatus with identification means
    • A61M2205/6063—Optical identification systems
    • A61M2205/6081—Colour codes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Auxiliary Devices For And Details Of Packaging Control (AREA)
KE3860A 1982-10-08 1989-02-15 Devices for administering medicaments to patients KE3860A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8228887 1982-10-08
GB838314307A GB8314307D0 (en) 1983-05-24 1983-05-24 Medical administration devices

Publications (1)

Publication Number Publication Date
KE3860A true KE3860A (en) 1989-06-02

Family

ID=26284076

Family Applications (1)

Application Number Title Priority Date Filing Date
KE3860A KE3860A (en) 1982-10-08 1989-02-15 Devices for administering medicaments to patients

Country Status (30)

Country Link
US (1) US4627432A (fr)
JP (2) JPH05200100A (fr)
KR (1) KR910002248B1 (fr)
AT (1) AT396333B (fr)
AU (2) AU570013B2 (fr)
BR (1) BR8305562A (fr)
CA (1) CA1224992A (fr)
CH (1) CH662277A5 (fr)
CY (2) CY1477A (fr)
DE (1) DE3336486A1 (fr)
DK (1) DK172541B1 (fr)
ES (1) ES286422Y (fr)
FI (1) FI79651C (fr)
FR (2) FR2550452B1 (fr)
GB (1) GB2129691B (fr)
GR (1) GR79615B (fr)
HK (1) HK67789A (fr)
IE (1) IE56059B1 (fr)
IL (1) IL69932A (fr)
IN (1) IN160851B (fr)
IT (1) IT1203660B (fr)
KE (1) KE3860A (fr)
LU (1) LU85034A1 (fr)
NL (1) NL192564C (fr)
NO (1) NO160330C (fr)
NZ (1) NZ205892A (fr)
PT (1) PT77471B (fr)
SE (2) SE458824B (fr)
SG (1) SG6889G (fr)
ZW (1) ZW21483A1 (fr)

Families Citing this family (395)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3348370C2 (de) * 1982-10-08 2001-10-11 Glaxo Group Ltd Medikamenten-Packung und Verfahren zur Erzeugung eines zur Inhalation bestimmten Medikamenten-Pulver-Luftstroms
SE448277B (sv) * 1985-04-12 1987-02-09 Draco Ab Indikeringsanordning vid en doseringsanordning for lekemedel
PT83094B (pt) * 1985-07-30 1993-07-30 Glaxo Group Ltd Dispositivos proprios para a administracao de medicamentos a pacientes
SE8605130L (sv) * 1986-07-24 1988-01-25 Marcus Diamant Redskap for utklemning av tabletter fran tablettkartor och liknande
US4817800A (en) * 1987-05-20 1989-04-04 Surgikos, Inc. Fluid injection system cassette and fluid packaging methods
FR2626500B1 (fr) * 1988-01-28 1990-04-27 Valois Sa Poussoir de vaporisateur agence pour operer le melange d'un additif dans l'emission du jet
CH678151A5 (en) * 1988-07-13 1991-08-15 Heinz Hermann Weick Self-medication nasal dispenser
US5239991A (en) * 1989-06-21 1993-08-31 Fisons Plc Disposable powder medicament inhalation device with peel-off cover
GB8914223D0 (en) * 1989-06-21 1989-08-09 Fisons Plc Medicament container
IT1230313B (it) * 1989-07-07 1991-10-18 Somova Spa Inalatore per medicamenti in capsule.
DE3927170A1 (de) * 1989-08-17 1991-02-21 Boehringer Ingelheim Kg Inhalator
US5009561A (en) * 1989-08-18 1991-04-23 Pharmacia Diagnostics Inc. Reagent tablet dispenser
GB9004781D0 (en) * 1990-03-02 1990-04-25 Glaxo Group Ltd Device
SK280967B6 (sk) * 1990-03-02 2000-10-09 Glaxo Group Limited Inhalačný prístroj
YU48707B (sh) 1990-03-02 1999-07-28 Glaxo Group Limited Aparat za inhaliranje - inhalator
US6536427B2 (en) 1990-03-02 2003-03-25 Glaxo Group Limited Inhalation device
GB9012870D0 (en) * 1990-06-08 1990-08-01 Glaxo Group Ltd Device
DE4021263C2 (de) * 1990-07-04 1996-04-11 Pfeiffer Erich Gmbh & Co Kg Austragvorrichtung für Medien
IT1243344B (it) * 1990-07-16 1994-06-10 Promo Pack Sa Inalatore plurimonodose per medicamenti in polvere
GB9021433D0 (en) * 1990-10-02 1990-11-14 Atomic Energy Authority Uk Power inhaler
FR2667509B1 (fr) * 1990-10-04 1995-08-25 Valois Inhalateur a poudre, dispositif de conditionnement de microdoses de poudre sous forme de bandes adaptees a etre utilisees dans un inhalateur a poudre, et procede de fabrication de ces bandes.
US5042472A (en) * 1990-10-15 1991-08-27 Merck & Co., Inc. Powder inhaler device
NL9002706A (nl) * 1990-12-10 1992-07-01 Pharmachemie Bv Inrichting ten gebruike bij het inhaleren van in staafvormige capsules verpakte poedervormige stoffen.
GB2253200A (en) * 1991-02-01 1992-09-02 Harris Pharma Ltd Inhalation apparatus and fracturable capsule for use therewith
US5243970A (en) * 1991-04-15 1993-09-14 Schering Corporation Dosing device for administering metered amounts of powdered medicaments to patients
US5327883A (en) * 1991-05-20 1994-07-12 Dura Pharmaceuticals, Inc. Apparatus for aerosolizing powdered medicine and process and using
US6681767B1 (en) 1991-07-02 2004-01-27 Nektar Therapeutics Method and device for delivering aerosolized medicaments
US5337740A (en) * 1991-08-01 1994-08-16 New England Pharmaceuticals, Inc. Inhalation devices
US5161524A (en) * 1991-08-02 1992-11-10 Glaxo Inc. Dosage inhalator with air flow velocity regulating means
DE4142238A1 (de) * 1991-12-20 1993-06-24 Boehringer Ingelheim Kg Pulverinhalator mit pulvertraeger aus regelmaessigen mikrostrukturen
GB2264237A (en) * 1992-02-05 1993-08-25 Robert Edward Newell An inhaler
GB9203761D0 (en) * 1992-02-21 1992-04-08 Innovata Biomed Ltd Inhaler
US5301664A (en) * 1992-03-06 1994-04-12 Sievers Robert E Methods and apparatus for drug delivery using supercritical solutions
US5394868A (en) * 1992-06-25 1995-03-07 Schering Corporation Inhalation device for powdered medicaments
US6509006B1 (en) 1992-07-08 2003-01-21 Inhale Therapeutic Systems, Inc. Devices compositions and methods for the pulmonary delivery of aerosolized medicaments
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US5785049A (en) 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
RO113214B1 (ro) * 1992-10-19 1998-05-29 Dura Pharma Inc Inhalator de pulbere uscata
SE9203743D0 (sv) * 1992-12-11 1992-12-11 Astra Ab Efficient use
US6250300B1 (en) 1992-12-11 2001-06-26 Ab Astra System for dispensing pharmaceutically active compounds
US5368187A (en) * 1993-01-19 1994-11-29 Poncetta; Stanley Method and apparatus for dispensing materials from blister packages
US5873358A (en) * 1993-01-29 1999-02-23 Aradigm Corporation Method of maintaining a diabetic patient's blood glucose level in a desired range
US5888477A (en) * 1993-01-29 1999-03-30 Aradigm Corporation Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin
US6012450A (en) * 1993-01-29 2000-01-11 Aradigm Corporation Intrapulmonary delivery of hematopoietic drug
US5970973A (en) * 1993-01-29 1999-10-26 Aradigm Corporation Method of delivering insulin lispro
US7448375B2 (en) 1993-01-29 2008-11-11 Aradigm Corporation Method of treating diabetes mellitus in a patient
US5915378A (en) * 1993-01-29 1999-06-29 Aradigm Corporation Creating an aerosolized formulation of insulin
US5934272A (en) * 1993-01-29 1999-08-10 Aradigm Corporation Device and method of creating aerosolized mist of respiratory drug
US6131567A (en) * 1993-01-29 2000-10-17 Aradigm Corporation Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
US5743250A (en) 1993-01-29 1998-04-28 Aradigm Corporation Insulin delivery enhanced by coached breathing
US6024090A (en) 1993-01-29 2000-02-15 Aradigm Corporation Method of treating a diabetic patient by aerosolized administration of insulin lispro
US5672581A (en) * 1993-01-29 1997-09-30 Aradigm Corporation Method of administration of insulin
US6098620A (en) * 1993-01-29 2000-08-08 Aradigm Corporation Device for aerosolizing narcotics
US5558085A (en) * 1993-01-29 1996-09-24 Aradigm Corporation Intrapulmonary delivery of peptide drugs
US5724957A (en) * 1993-01-29 1998-03-10 Aradigm Corporation Intrapulmonary delivery of narcotics
US5819726A (en) * 1993-01-29 1998-10-13 Aradigm Corporation Method for the delivery of aerosolized drugs to the lung for the treatment of respiratory disease
KR960701672A (ko) * 1993-03-03 1996-03-28 윌리엄 피. 알트만 건조 분말 흡입기의 약제 캐리어(dry powder inhalator medicament carrier)
TW360548B (en) * 1993-04-08 1999-06-11 Powderject Res Ltd Products for therapeutic use
US5372128A (en) * 1993-04-14 1994-12-13 Habley Medical Technology Corporation Fluidizing powder inhaler
US5709202A (en) * 1993-05-21 1998-01-20 Aradigm Corporation Intrapulmonary delivery of aerosolized formulations
US5497763A (en) * 1993-05-21 1996-03-12 Aradigm Corporation Disposable package for intrapulmonary delivery of aerosolized formulations
US5533502A (en) * 1993-05-28 1996-07-09 Vortran Medical Technology, Inc. Powder inhaler with aerosolization occurring within each individual powder receptacle
US5388572A (en) * 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
US5388573A (en) * 1993-12-02 1995-02-14 Tenax Corporation Dry powder inhalator medicament carrier
US6051256A (en) 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
KR100419037B1 (ko) 1994-03-07 2004-06-12 넥타르 테라퓨틱스 폐를통한인슐린의전달방법및그조성물
US5664557A (en) * 1994-03-10 1997-09-09 Respiratory Delivery Systems, Inc. Releasably engageable coupling for an inhaler
US6102036A (en) * 1994-04-12 2000-08-15 Smoke-Stop Breath activated inhaler
GB9409851D0 (en) * 1994-05-17 1994-07-06 Cambridge Consultants Improvements in and relating to containers of particulate material
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
EP0846009B1 (fr) * 1994-09-21 2008-03-05 Nektar Therapeutics Appareil et procede de dispersion de medicaments pulverulents secs
US5522385A (en) * 1994-09-27 1996-06-04 Aradigm Corporation Dynamic particle size control for aerosolized drug delivery
FR2725626A1 (fr) * 1994-10-18 1996-04-19 Sofab Dispositif pour l'inhalation de produits en poudre
DE19500764C2 (de) * 1995-01-13 2001-09-27 Sofotec Gmbh & Co Kg Vorrichtung zum Verabreichen von Medikamenten in fester, in einem Luftstrom fein verteilter Form
DE19502725B4 (de) * 1995-01-28 2004-03-04 Ing. Erich Pfeiffer Gmbh & Co Kg Austragvorrichtung für Medien
US5676643A (en) * 1995-02-13 1997-10-14 The Procter & Gamble Company Dispenser for friably releasing dry particulate medicaments
US5780014A (en) * 1995-04-14 1998-07-14 Inhale Therapeutic Systems Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
US5921237A (en) * 1995-04-24 1999-07-13 Dura Pharmaceuticals, Inc. Dry powder inhaler
US5622166A (en) * 1995-04-24 1997-04-22 Dura Pharmaceuticals, Inc. Dry powder inhaler delivery system
US5669973A (en) * 1995-06-06 1997-09-23 David Sarnoff Research Center, Inc. Apparatus for electrostatically depositing and retaining materials upon a substrate
US5714007A (en) * 1995-06-06 1998-02-03 David Sarnoff Research Center, Inc. Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate
US20040237961A1 (en) * 1995-06-08 2004-12-02 Snow John Medlin Inhalation actuated device for use with metered dose inhalers (MDIs)
US6672304B1 (en) 1995-06-08 2004-01-06 Innovative Devices, Llc Inhalation actuated device for use with metered dose inhalers (MDIs)
DE19523516C1 (de) * 1995-06-30 1996-10-31 Asta Medica Ag Inhalator zum Verabreichen von Medikamenten aus Blisterpackungen
US5642727A (en) * 1995-07-25 1997-07-01 David Sarnoff Research Center, Inc. Inhaler apparatus using a tribo-electric charging technique
US5988163A (en) * 1995-08-02 1999-11-23 Innovative Devices Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of delivery of medicament
US5823183A (en) * 1995-08-02 1998-10-20 Innovative Devices Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
US5692496A (en) * 1995-08-02 1997-12-02 Innovative Devices, Llc Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
US6209538B1 (en) 1995-08-02 2001-04-03 Robert A. Casper Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
NL1001031C1 (nl) * 1995-08-23 1997-02-25 Npk Ind Design B V Inrichting voor het afgeven van pillen uit een blisterverpakking.
US6182655B1 (en) 1995-12-07 2001-02-06 Jago Research Ag Inhaler for multiple dosed administration of a pharmacological dry powder
US7131441B1 (en) 1995-12-07 2006-11-07 Skyepharma Ag Inhaler for multiple dosed administration of a pharmacological dry powder
US5669378A (en) * 1995-12-21 1997-09-23 Pera; Ivo Inhaling device
US5823179A (en) 1996-02-13 1998-10-20 1263152 Ontario Inc. Nebulizer apparatus and method
US5743251A (en) * 1996-05-15 1998-04-28 Philip Morris Incorporated Aerosol and a method and apparatus for generating an aerosol
US5857456A (en) * 1996-06-10 1999-01-12 Sarnoff Corporation Inhaler apparatus with an electronic means for enhanced release of dry powders
US5871010A (en) * 1996-06-10 1999-02-16 Sarnoff Corporation Inhaler apparatus with modified surfaces for enhanced release of dry powders
US5985248A (en) 1996-12-31 1999-11-16 Inhale Therapeutic Systems Processes for spray drying solutions of hydrophobic drugs and compositions thereof
US20030203036A1 (en) 2000-03-17 2003-10-30 Gordon Marc S. Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
DE19704849B4 (de) * 1997-02-08 2011-02-17 Ing. Erich Pfeiffer Gmbh Austragvorrichtung für Medien
US6006747A (en) * 1997-03-20 1999-12-28 Dura Pharmaceuticals, Inc. Dry powder inhaler
US5909822A (en) * 1997-05-03 1999-06-08 George; Donald C. Pill dispenser employing a sealed pill carrier
US5915560A (en) * 1997-05-03 1999-06-29 George; Donald C. Compartmentalized pill dispenser
ATE432727T1 (de) 1997-12-02 2009-06-15 Valois Sas Trockenpulverinhalator
US6116238A (en) * 1997-12-02 2000-09-12 Dura Pharmaceuticals, Inc. Dry powder inhaler
EP1047467B1 (fr) 1998-01-16 2004-06-23 1263152 Ontario Inc. Dispositif indicateur a utiliser conjointement avec un dispositif distributeur
CN1292714B (zh) 1998-03-16 2012-08-01 诺瓦帝斯公司 气溶胶化活性剂的输送
US6336453B1 (en) 1999-04-30 2002-01-08 Trudell Medical International Indicating device for aerosol container
US6729330B2 (en) 1998-05-05 2004-05-04 Trudell Medical International Indicating device for aerosol container
US6082358A (en) 1998-05-05 2000-07-04 1263152 Ontario Inc. Indicating device for aerosol container
US6257233B1 (en) 1998-06-04 2001-07-10 Inhale Therapeutic Systems Dry powder dispersing apparatus and methods for their use
US6149774A (en) 1998-06-10 2000-11-21 Delsys Pharmaceutical Corporation AC waveforms biasing for bead manipulating chucks
DE19831525A1 (de) * 1998-07-14 2000-01-20 Pfeiffer Erich Gmbh & Co Kg Spender für Medien
UA73924C2 (en) 1998-10-09 2005-10-17 Nektar Therapeutics Device for delivering active agent formulation to lungs of human patient
US6234167B1 (en) 1998-10-14 2001-05-22 Chrysalis Technologies, Incorporated Aerosol generator and methods of making and using an aerosol generator
US6923979B2 (en) 1999-04-27 2005-08-02 Microdose Technologies, Inc. Method for depositing particles onto a substrate using an alternating electric field
DE29908593U1 (de) 1999-05-14 1999-07-22 Jago Research AG, Hergiswil Mundstück für einen Inhalator zur Abgabe eines Medikaments
CA2373278C (fr) 1999-06-05 2011-04-05 Innovata Biomed Limited Dispositif medical d'administration de medicament avec chambre de mesure et coupelle de mesure
US6606992B1 (en) 1999-06-30 2003-08-19 Nektar Therapeutics Systems and methods for aerosolizing pharmaceutical formulations
US6730066B1 (en) * 1999-08-03 2004-05-04 Pharmacia Ab Liquid delivery container
GB9920839D0 (en) 1999-09-04 1999-11-10 Innovata Biomed Ltd Inhaler
US6810872B1 (en) * 1999-12-10 2004-11-02 Unisia Jecs Corporation Inhalant medicator
US20010029947A1 (en) 1999-12-17 2001-10-18 Steve Paboojian Receptacles to facilitate the extraction of powders
US7069929B2 (en) * 2000-02-01 2006-07-04 Quadrant Technologies Limited Dry powder inhaler
US6427688B1 (en) * 2000-02-01 2002-08-06 Dura Pharmaceuticals, Icn. Dry powder inhaler
EP1261316B1 (fr) 2000-02-28 2008-04-23 PharmaKodex Limited Appareil pour l'administration de medicaments par voie orale
US6883516B2 (en) 2000-04-27 2005-04-26 Chrysalis Technologies Incorporated Method for generating an aerosol with a predetermined and/or substantially monodispersed particle size distribution
MY136453A (en) 2000-04-27 2008-10-31 Philip Morris Usa Inc "improved method and apparatus for generating an aerosol"
US6948494B1 (en) 2000-05-10 2005-09-27 Innovative Devices, Llc. Medicament container with same side airflow inlet and outlet and method of use
GB0015034D0 (en) * 2000-06-21 2000-08-09 Glaxo Group Ltd Inhalation device
TWI224515B (en) * 2000-06-23 2004-12-01 Norton Healthcare Ltd Pre-metered dose magazine for breath-actuated dry powder inhaler
US7575761B2 (en) 2000-06-30 2009-08-18 Novartis Pharma Ag Spray drying process control of drying kinetics
CO5310534A1 (es) 2000-08-05 2003-08-29 Glaxo Group Ltd Nuevos derivados de androstano anti-inflamatorios
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6948492B2 (en) * 2000-08-15 2005-09-27 University Of Kentucky Research Foundation Programmable multi-dose intranasal drug delivery device
US6681998B2 (en) 2000-12-22 2004-01-27 Chrysalis Technologies Incorporated Aerosol generator having inductive heater and method of use thereof
US7077130B2 (en) 2000-12-22 2006-07-18 Chrysalis Technologies Incorporated Disposable inhaler system
US6799572B2 (en) 2000-12-22 2004-10-05 Chrysalis Technologies Incorporated Disposable aerosol generator system and methods for administering the aerosol
US6501052B2 (en) 2000-12-22 2002-12-31 Chrysalis Technologies Incorporated Aerosol generator having multiple heating zones and methods of use thereof
US6491233B2 (en) 2000-12-22 2002-12-10 Chrysalis Technologies Incorporated Vapor driven aerosol generator and method of use thereof
US6701921B2 (en) 2000-12-22 2004-03-09 Chrysalis Technologies Incorporated Aerosol generator having heater in multilayered composite and method of use thereof
GB0103630D0 (en) 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds
ES2375333T3 (es) 2001-03-20 2012-02-28 Trudell Medical International Aparato nebulizador.
EP1370521B1 (fr) 2001-03-22 2007-12-19 Glaxo Group Limited Derives formanilides utilises en tant qu'agonistes de l'adrenorecepteur beta2
CA2445839A1 (fr) 2001-04-30 2002-11-07 Glaxo Group Limited Derives anti-inflammatoires d'androstane 17.beta.-carbothioate ester avec un groupe cyclique en position 17.alpha
US6745760B2 (en) 2001-05-15 2004-06-08 Trudell Medical International Medicament applicator
US8061006B2 (en) 2001-07-26 2011-11-22 Powderject Research Limited Particle cassette, method and kit therefor
US7176278B2 (en) 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
NZ531651A (en) 2001-09-14 2006-02-24 Glaxo Group Ltd Phenethanolamine derivatives for treatment of respiratory diseases
US8337816B2 (en) 2001-09-17 2012-12-25 Glaxo Group Limited Dry powder medicament formulations
WO2003024514A1 (fr) 2001-09-19 2003-03-27 Advent Pharmaceuticals Pty Ltd Inhaleur
US6568390B2 (en) 2001-09-21 2003-05-27 Chrysalis Technologies Incorporated Dual capillary fluid vaporizing device
US6640050B2 (en) 2001-09-21 2003-10-28 Chrysalis Technologies Incorporated Fluid vaporizing device having controlled temperature profile heater/capillary tube
US7931022B2 (en) * 2001-10-19 2011-04-26 Respirks, Inc. Method and apparatus for dispensing inhalator medicament
GB0128148D0 (en) 2001-11-23 2002-01-16 Innovata Biomed Ltd Assembly
US6804458B2 (en) * 2001-12-06 2004-10-12 Chrysalis Technologies Incorporated Aerosol generator having heater arranged to vaporize fluid in fluid passage between bonded layers of laminate
US6681769B2 (en) 2001-12-06 2004-01-27 Crysalis Technologies Incorporated Aerosol generator having a multiple path heater arrangement and method of use thereof
US6701922B2 (en) 2001-12-20 2004-03-09 Chrysalis Technologies Incorporated Mouthpiece entrainment airflow control for aerosol generators
US7458373B2 (en) 2002-01-15 2008-12-02 Philip Morris Usa Inc. Aerosol generator for drug formulation
GB0217199D0 (en) * 2002-07-25 2002-09-04 Glaxo Group Ltd Medicament dispenser
GB0201677D0 (en) * 2002-01-25 2002-03-13 Glaxo Group Ltd Medicament dispenser
AU2003216401A1 (en) * 2002-03-01 2003-09-16 Glaxo Group Limited Rotary blending apparatus and system
CA2477604A1 (fr) 2002-03-13 2003-09-25 Signum Biosciences, Inc. Modulation de la methylation de proteines et du phosphate des phosphoproteines
US7004164B2 (en) 2002-03-21 2006-02-28 Trudell Medical International Indicating device for aerosol container
JP2006504446A (ja) * 2002-03-26 2006-02-09 グラクソ　グループ　リミテッド ラミネート・アセンブリーの形成方法、およびそれにより形成される製品
US20030235538A1 (en) 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
UA80123C2 (en) * 2002-04-09 2007-08-27 Boehringer Ingelheim Pharma Inhalation kit comprising inhalable powder of tiotropium
DE10217929A1 (de) * 2002-04-22 2003-11-06 Sixp Ag Vorrichtung zur Ausgabe von Tabletten
GB0216562D0 (en) 2002-04-25 2002-08-28 Bradford Particle Design Ltd Particulate materials
US7271197B2 (en) * 2002-04-25 2007-09-18 Glaxo Group Limited Phenethanolamine derivatives
AU2003228683A1 (en) * 2002-04-25 2003-11-10 Glaxo Group Limited Magnetoacoustic sensor system and associated method for sensing environmental conditions
GB2388040B (en) * 2002-05-02 2005-12-14 Robert Jeremy West Nicotine inhalation device
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
AU2003222642A1 (en) * 2002-05-10 2003-11-11 Chrysalis Technologies Incorporated Aerosol generator for drug formulation and methods of generating aerosol
US7089786B2 (en) * 2002-05-15 2006-08-15 Glaxo Group Limited Microelectromechanical system and method for determining temperature and moisture profiles within pharmaceutical packaging
US6904908B2 (en) 2002-05-21 2005-06-14 Trudell Medical International Visual indicator for an aerosol medication delivery apparatus and system
US7185651B2 (en) 2002-06-18 2007-03-06 Nektar Therapeutics Flow regulator for aerosol drug delivery and methods
GB0217198D0 (en) * 2002-07-25 2002-09-04 Glaxo Group Ltd Medicament dispenser
US20050251289A1 (en) * 2002-07-25 2005-11-10 Bonney Stanley G Medicament dispenser
GB0217225D0 (en) 2002-07-25 2002-09-04 Glaxo Group Ltd Medicinal compounds
GB0217196D0 (en) * 2002-07-25 2002-09-04 Glaxo Group Ltd Medicament dispenser
EP1534367A1 (fr) * 2002-07-25 2005-06-01 Glaxo Group Limited Distributeur de medicament
CA2497871C (fr) 2002-09-06 2012-04-17 Chrysalis Technologies Incorporated Dispositifs de production d'aerosol et procedes de production d'aerosols a dimensions granulometriques regulees
EP1565256A4 (fr) * 2002-09-13 2008-05-07 Glaxo Group Ltd Systeme de melangeage a revetement
US6772757B2 (en) 2002-10-25 2004-08-10 Chrysalis Technologies Incorporated Concentric controlled temperature profile fluid vaporizing device
BR0315720A (pt) 2002-10-28 2005-09-06 Glaxo Group Ltd Composto, método para a profilaxia ou tratamento de uma condição clìnica em um mamìmefero, formulação farmacêutica, combinação, uso de um composto, processo para a preparação de um composto, e, intermediário
US20060076010A1 (en) * 2002-12-18 2006-04-13 King Michael L Drug delivery system with vented mouthpiece
US20040173211A1 (en) * 2003-01-14 2004-09-09 Boehringer Ingelheim International Gmbh Powder inhaler
CA2515212A1 (fr) * 2003-02-05 2004-08-19 Martin John Tedham Distributeur
GB0303396D0 (en) 2003-02-14 2003-03-19 Glaxo Group Ltd Medicinal compounds
DE10317461A1 (de) 2003-04-16 2004-10-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
EP1488819A1 (fr) * 2003-06-16 2004-12-22 Rijksuniversiteit te Groningen Inhalateur de poudre sèche et procédé d'inhalation pulmonaire de poudre sèche
GB0315509D0 (en) 2003-07-02 2003-08-06 Meridica Ltd Dispensing device
TW200519108A (en) 2003-07-17 2005-06-16 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
US7367334B2 (en) 2003-08-27 2008-05-06 Philip Morris Usa Inc. Fluid vaporizing device having controlled temperature profile heater/capillary tube
KR20080067023A (ko) 2003-10-14 2008-07-17 글락소 그룹 리미티드 무스카린성 아세틸콜린 수용체 길항제
US7507747B2 (en) 2003-10-17 2009-03-24 Glaxo Group Limited Muscarinic acetylcholine receptor antagonists
US20070277820A1 (en) * 2003-10-27 2007-12-06 Timothy Crowder Blister packages and associated methods of fabricating dry powder drug containment systems
US7621273B2 (en) 2003-10-28 2009-11-24 Trudell Medical International Indicating device with warning dosage indicator
AR046225A1 (es) 2003-11-04 2005-11-30 Glaxo Group Ltd Compuesto de 8-azoniabiciclo(3.2.1)octano, composicion farmaceutica para el tratamiento de enfermedades mediadas por receptores de acetilcolina muscarinicos que lo comprende y uso del compuesto para preparar dicha composicion
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
WO2005053647A1 (fr) * 2003-12-03 2005-06-16 Microdrug Ag Produit medical contenant du tiotropium
SE0303270L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Metod för administration av tiotropium
US7100530B2 (en) 2003-12-15 2006-09-05 Trudell Medical International, Inc. Dose indicating device
GB0329182D0 (en) 2003-12-17 2004-01-21 Glaxo Group Ltd Chemical compounds
US8147426B2 (en) * 2003-12-31 2012-04-03 Nipro Diagnostics, Inc. Integrated diagnostic test system
EP1725564A4 (fr) 2004-03-17 2007-09-12 Glaxo Group Ltd Antagonistes du recepteur d'acetylcholine muscarinique m3
US7846973B2 (en) 2004-04-02 2010-12-07 Theravance, Inc. Chemical process and new crystalline form
JP2007533387A (ja) 2004-04-21 2007-11-22 イノベータ バイオメド リミテッド 吸入器
GB0409197D0 (en) 2004-04-24 2004-05-26 Innovata Biomed Ltd Device
AR050902A1 (es) 2004-04-27 2006-12-06 Glaxo Group Ltd Compuesto de quinuclidina, composicion farmaceutica que lo comprende y su usopara preparar dicha composicion
JP2007537261A (ja) 2004-05-13 2007-12-20 グラクソ　グループ　リミテッド ムスカリン性アセチルコリン受容体アンタゴニスト
GB0418738D0 (en) * 2004-08-23 2004-09-22 3M Innovative Properties Co Medicinal aerosol formulation receptacle and production thereof
US7543582B2 (en) 2004-09-20 2009-06-09 Trudell Medical International Dose indicating device with display elements attached to container
MX2007004768A (es) * 2004-10-21 2007-05-10 Boehringer Ingelheim Int Blister para inhaladores.
WO2006047663A2 (fr) * 2004-10-26 2006-05-04 The University Of North Carolina At Chapel Hill Filament enduit pour production d'aerosols par evaporation/condensation d'agents therapeutiques et methodes d'utilisation
JP2006130143A (ja) * 2004-11-08 2006-05-25 Hitachi Ltd 吸入式投薬器及び薬剤カートリッジ
US20080042823A1 (en) * 2004-11-12 2008-02-21 Heasley Matthew G Sensor System with Acoustic Transducer
WO2006077486A1 (fr) 2005-01-20 2006-07-27 Trudell Medical International Dispositif de distribution
US7923041B2 (en) 2005-02-03 2011-04-12 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
EP1843734A4 (fr) 2005-02-03 2008-09-10 Signum Biosciences Inc Compositions et procedes pour l'amelioration de la fonction cognitive
CA2597557A1 (fr) 2005-02-10 2006-08-17 Glaxo Group Limited Procedes de fabrication du lactose au moyen de techniques de pre-classification et preparations pharmaceutiques ainsi obtenues
UY29439A1 (es) 2005-03-25 2006-10-02 Glaxo Group Ltd Nuevos compuestos
MY145343A (en) 2005-03-25 2012-01-31 Glaxo Group Ltd Novel compounds
GB0507711D0 (en) 2005-04-15 2005-05-25 Vectura Group Plc Improved blister piercing
US8653028B2 (en) * 2005-04-29 2014-02-18 Rui Rong Yuan Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators
US9585932B2 (en) 2005-04-29 2017-03-07 Peter C. Dowling Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders
US9345745B2 (en) 2005-04-29 2016-05-24 Bo Wang Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides
US20090042843A1 (en) * 2005-05-04 2009-02-12 Boehringer Ingelheim International Gmbh Inhalation Device Containing Plural Doses of a Pharmaceutical Composition
DE102005035705A1 (de) * 2005-07-27 2007-02-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Arzneimittelblister
JP2009504768A (ja) 2005-08-18 2009-02-05 グラクソ グループ リミテッド ムスカリン性アセチルコリン受容体アンタゴニスト
WO2007024876A2 (fr) * 2005-08-24 2007-03-01 The Board Of Trustees Of Leland Stanford Junior University Methodes de traitement et de surveillance de l'inflammation et du desequilibre d'oxydoreduction dans la mucoviscidose
US20090192227A1 (en) * 2005-08-24 2009-07-30 Rabindra Tirouvanziam N-Acetylcysteine Compositions and Methods for Treating Acute Exacerbations of Inflammatory Lung Disease
TWI274641B (en) * 2005-08-30 2007-03-01 Rexon Ind Corp Ltd Cutting machine
US8227408B2 (en) * 2005-09-07 2012-07-24 Neurotez, Inc. Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
US20070178141A1 (en) * 2005-09-07 2007-08-02 Bebaas, Inc. Vitamin B12 compositions
US20130131007A1 (en) 2005-09-07 2013-05-23 Bebaas, Inc. Vitamin b12 compositions
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
EP1795221A1 (fr) * 2005-12-02 2007-06-13 Boehringer Ingelheim Pharma GmbH & Co. KG Appareil pour distribuer, stocker, et méthode pour distribuer une formulation
US8037880B2 (en) * 2006-04-07 2011-10-18 The University Of Western Ontario Dry powder inhaler
EP1844808A1 (fr) * 2006-04-13 2007-10-17 BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Dispositif pour délivrer un médicament
EP1844809A1 (fr) * 2006-04-13 2007-10-17 Boehringer Ingelheim Pharma GmbH & Co. KG Réservoir d'inhalateur, et inhalateur multi-doses
DE102006043637A1 (de) * 2006-05-18 2007-11-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Zerstäuber
DE102006023662A1 (de) * 2006-05-18 2007-11-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalator
US9457161B2 (en) 2006-05-18 2016-10-04 Boehringer Ingelheim International Gmbh Inhaler
US8141550B2 (en) 2006-08-01 2012-03-27 Trudell Medical International Dispensing device
MX2009001944A (es) 2006-08-21 2009-04-16 Trudell Medical Int Dispositivo de entrenamiento de resistencia del musculo respiratorio y metodo para usar el mismo.
DE102006045788A1 (de) * 2006-09-26 2008-03-27 Alfred Von Schuckmann Spender für pulverförmige Massen
US8573197B2 (en) * 2006-10-25 2013-11-05 Novartis Ag Powder dispersion apparatus, method of making and using the apparatus, and components that can be used on the apparatus and other devices
GB0621957D0 (en) * 2006-11-03 2006-12-13 Vectura Group Plc Inhaler devices and bespoke pharmaceutical compositions
EP1925295A1 (fr) 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Formule de poudre stable contenant un nouveau anticholinergique
BRPI0806474A2 (pt) 2007-01-09 2011-09-27 Mystic Pharmaceuticals Inc dispositivos de cartucho intranasal
CA2689296C (fr) * 2007-01-10 2015-11-17 Purdue Research Foundation Inhibiteurs polypeptidiques de la hsp27 kinase et leurs utilisations
PE20081889A1 (es) 2007-03-23 2009-03-05 Smithkline Beecham Corp Indol carboxamidas como inhibidores de ikk2
EP1992374A1 (fr) * 2007-05-16 2008-11-19 Boehringer Ingelheim Pharma GmbH & Co. KG Dispositif distributeur
EP1992376A1 (fr) 2007-05-16 2008-11-19 Boehringer Ingelheim Pharma GmbH & Co. KG Dispositif distributeur
EP1992373A1 (fr) 2007-05-16 2008-11-19 Boehringer Ingelheim Pharma GmbH & Co. KG Dispositif distributeur
EP1992372A1 (fr) 2007-05-16 2008-11-19 Boehringer Ingelheim Pharma GmbH & Co. KG Dispositif de distribution
EP1992379A1 (fr) * 2007-05-16 2008-11-19 Boehringer Ingelheim Pharma GmbH & Co. KG Dispositif distributeur
EP1992380A1 (fr) 2007-05-16 2008-11-19 Boehringer Ingelheim Pharma GmbH & Co. KG Dispositif distributeur
US9248076B2 (en) 2007-05-16 2016-02-02 Mystic Pharmaceuticals, Inc. Dose dispensing containers
EP1992377A1 (fr) * 2007-05-16 2008-11-19 Boehringer Ingelheim Pharma GmbH & Co. KG Dispositif distributeur
EP1992378A1 (fr) * 2007-05-16 2008-11-19 Boehringer Ingelheim Pharma GmbH & Co. KG Dispositif distributeur
AT505246B8 (de) * 2007-06-01 2009-06-15 Croma Pharma Gmbh Container für eine mehrzahl von einzeldosen sowie applikator für derartige container
WO2008145348A2 (fr) * 2007-06-01 2008-12-04 Boehringer Ingelheim International Gmbh Dispositif de distribution
WO2009021137A2 (fr) 2007-08-07 2009-02-12 Purdue Research Foundation Inhibiteurs de kinase et leurs utilisations
EP2042208A1 (fr) * 2007-09-25 2009-04-01 Boehringer Ingelheim Pharma GmbH & Co. KG Dispositif distributeur
EP2077132A1 (fr) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispositif distributeur, dispositif de stockage et procédé pour la distribution d'une formulation
EP2082763A1 (fr) * 2008-01-24 2009-07-29 Boehringer Ingelheim International Gmbh Inhalateur
US20110203586A1 (en) * 2008-02-20 2011-08-25 Boehringer Ingelheim International Gmbh Powder Inhalers
EP2259849A2 (fr) 2008-02-21 2010-12-15 Trudell Medical International Dispositif d'entraînement en endurance des muscles respiratoires et son procédé d'utilisation
US20090235929A1 (en) * 2008-03-19 2009-09-24 Marc Egen Powder inhalers
US8082873B2 (en) 2008-05-05 2011-12-27 Trudell Medical International Drive mechanism for an indicating device
CN102099048A (zh) * 2008-05-21 2011-06-15 纽若泰兹公司 用于治疗与神经原纤维缠结有关的进行性认知障碍的方法
US8181591B1 (en) 2008-05-23 2012-05-22 Trudell Medical International Domed actuator for indicating device
GB2463451A (en) 2008-09-08 2010-03-17 Cambridge Lab 3, 11b cis-dihydrotetrabenazine compounds for use in the treatment of dementia
KR101650075B1 (ko) 2008-09-26 2016-08-22 오리엘 테라퓨틱스, 인크. 이중 관통 부재들을 구비한 건조 분말 흡입기, 및 그와 관련된 장치 및 방법
AU2009296538B8 (en) 2008-09-26 2013-06-27 Oriel Therapeutics, Inc. Inhalers with airway disks having discrete airway channels and related disks and methods
CA2732826C (fr) * 2008-09-26 2017-08-22 Oriel Therapeutics, Inc. Mecanismes d'inhalateurs avec eperons sollicites radialement et procedes associes
US9050427B2 (en) * 2008-09-30 2015-06-09 Oriel Therapeutics, Inc. Dry powder inhalers with multi-facet surface deagglomeration chambers and related devices and methods
EP2328645B1 (fr) * 2008-10-01 2015-11-11 Oriel Therapeutics, Inc. Inhalateurs de poudre sèche à mécanismes de percement rotatifs, et dispositifs et procédés associés
JP5841429B2 (ja) * 2008-10-08 2016-01-13 アストラゼネカ・アクチエボラーグＡｓｔｒａｚｅｎｅｃａ Ａｋｔｉｅｂｏｌａｇ 可聴インジケータ手段を備えた吸入器
EP2349310B1 (fr) * 2008-10-20 2014-07-23 Moerae Matrix, Inc. Polypeptide pour traiter ou prévenir les adhésions
CA2905402C (fr) 2008-10-22 2017-02-28 Trudell Medical International Systeme modulaire d'administration d'aerosol
AU2009313562B2 (en) * 2008-11-04 2012-11-15 Neurotez, Inc. Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amlyoid beta
WO2010063645A1 (fr) * 2008-12-03 2010-06-10 Boehringer Ingelheim International Gmbh Inhalateur
CN102316731B (zh) * 2008-12-10 2016-06-01 普渡研究基金会 基于细胞渗透性肽的激酶抑制剂
GB0901520D0 (en) * 2009-01-30 2009-03-11 Vectura Delivery Devices Ltd Inhaler
LT3578169T (lt) 2009-02-26 2024-08-26 Glaxo Group Limited Farmaciniai preparatai, apimantys 4-{(1r)-2-[(6-{2-[(2,6-dichlorbenzil) oksi]etoksi}heksil)amino]-1-hidroksietil}-2-(hidroksimetil)fenolį
US9119924B2 (en) 2009-03-17 2015-09-01 Boehringer Ingelheim International Gmbh Dispensing device, storage device and method for dispensing a formulation
AU2010249402B2 (en) * 2009-05-21 2014-08-21 Microdose Therapeutx, Inc. Rotary cassette system for dry powder inhaler
US8985101B2 (en) 2009-05-21 2015-03-24 Microdose Therapeutx, Inc. Method and device for clamping a blister within a dry powder inhaler
MX2011013679A (es) 2009-06-16 2012-01-20 Schering Corp Esteroides de heteroarilo [3.2-c] novedosos como agonistas de receptor de glucocorticoide composiciones y uso de los mismos.
SG10201500620PA (en) 2009-07-24 2015-03-30 Amazentis Sa Compounds, compositions and methods for protecting brain health in neurodegenerative disorders
US9890195B2 (en) * 2009-07-27 2018-02-13 Purdue Research Foundation MK2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
MY187036A (en) 2010-01-05 2021-08-27 Microdose Therapeutx Inc Inhalation device and method
US8135497B2 (en) * 2010-01-13 2012-03-13 Joslyn Matthew I Portable, personal medication dispensing apparatus and method
EP2547307B1 (fr) 2010-03-18 2014-09-03 MedComb Holding ApS Systeme d'ouverture d'un emballage medical alveolaire
USD635246S1 (en) 2010-03-26 2011-03-29 Oriel Therapeutics, Inc. Dose disk for dry powder inhalers
USD641076S1 (en) 2010-03-26 2011-07-05 Oriel Therapeutics, Inc. Dry powder inhaler
ES2546422T5 (es) 2010-08-31 2023-01-20 Glaxosmithkline Ip Dev Ltd Productos medicinales de inhalación de polvo seco que presentan propiedades de control de la humedad y procedimientos de administración de los mismos
ES2705494T3 (es) 2010-08-31 2019-03-25 Glaxosmithkline Ip Dev Ltd Productos farmacológicos para la inhalación de polvo seco que presentan propiedades de control de la humedad y procedimientos de administración de los mismos
USD666492S1 (en) 2010-11-01 2012-09-04 Colgate-Palmolive Company Cap for a container
USD666493S1 (en) 2010-11-01 2012-09-04 Colgate-Palmolive Company Cap for a container
USD666096S1 (en) 2010-11-01 2012-08-28 Colgate-Palmolive Company Cap for a container
USD666098S1 (en) 2010-11-01 2012-08-28 Colgate-Palmolive Company Cap for a container
USD666097S1 (en) 2010-11-01 2012-08-28 Colgate-Palmolive Company Cap for a container
USD666099S1 (en) 2010-11-01 2012-08-28 Colgate-Palmolive Company Cap for a container
SG190793A1 (en) 2010-11-11 2013-07-31 Agency Science Tech & Res Targeting metabolic enzymes in human cancer
US9890200B2 (en) 2011-04-12 2018-02-13 Moerae Matrix, Inc. Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
CN108014340A (zh) 2011-04-12 2018-05-11 莫伊莱麦屈克斯公司 用于预防或治疗以成纤维细胞异常增殖及细胞外基质沉积为特征的疾病的组合物和方法
JP6012716B2 (ja) 2011-05-19 2016-10-25 サヴァラ，インク． 乾燥粉末バンコマイシン組成物および関連する方法
US8585659B2 (en) * 2011-05-31 2013-11-19 Mystic Pharmaceuticals, Inc. Piercing device for drug delivery systems
GB201116641D0 (en) 2011-09-27 2011-11-09 Glaxo Group Ltd Novel compounds
EP2589381B1 (fr) 2011-11-04 2016-08-31 Rabindra Tirouvanziam Compositions pour améliorer ou préserver une fonction de poumons chez un patient souffrant de troubles pulmonaires
US9452218B2 (en) 2012-03-09 2016-09-27 Purdue Research Foundation Compositions and methods for delivery of kinase inhibiting peptides
WO2013160418A1 (fr) 2012-04-27 2013-10-31 Glaxo Group Limited Nouveaux composés
GB201207406D0 (en) 2012-04-27 2012-06-13 Glaxo Group Ltd Novel compounds
ES2848025T3 (es) 2012-09-04 2021-08-05 Eleison Pharmaceuticals LLC Prevención de la recidiva pulmonar del cáncer con cisplatino complejado con lípidos
CA2891348C (fr) 2012-11-28 2020-04-28 Intercept Pharmaceuticals, Inc. Traitement d'une maladie pulmonaire
GB201301192D0 (en) 2013-01-23 2013-03-06 Vectura Delivery Devices Ltd A blister piercing element for a dry powder inhaler
JP2015037466A (ja) * 2013-04-08 2015-02-26 ニップファーマ株式会社 薬剤吸入デバイス
AU2014318821B2 (en) 2013-09-10 2018-04-19 Board Of Regents Of The University Of Texas System Therapeutics targeting truncated Adenomatous Polyposis Coli (APC) proteins
EP3057627B1 (fr) 2013-10-15 2018-07-25 Mystic Pharmaceuticals, Inc. Buse à turbulences à débit contrôlable
US10336788B2 (en) 2014-04-17 2019-07-02 Moerae Matrix, Inc. Inhibition of cardiac fibrosis in myocardial infarction
US10010484B2 (en) 2014-04-24 2018-07-03 Questa Corporation Multi-size pill splitter and methods
EP3142694A2 (fr) 2014-05-12 2017-03-22 Glaxosmithkline Intellectual Property (No. 2) Limited Compositions pharmaceutiques comprenant danirixin pour traiter des maladies infecteuses
US10082496B2 (en) 2014-09-10 2018-09-25 Board Of Regents Of The University Of Texas System Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
DK3212212T3 (da) 2014-10-31 2020-12-21 Univ Monash Pulverformulering
CA2967621A1 (fr) 2014-11-17 2016-05-26 Moerae Matrix, Inc. Compositions et procedes pour prevenir ou traiter des maladies, affections ou processus caracterises par une proliferation aberrante des fibroblastes et un depot de matrice extracellulaire
KR102674191B1 (ko) 2014-12-10 2024-06-11 하이퍼스템 에스에이 뇌암 줄기 세포의 성장, 이동 및 침습성 감소 그리고 뇌종양을 가진 환자의 생존 개선 방법 및 조성물
USD754919S1 (en) * 2014-12-19 2016-04-26 Fontem Holdings 4 B.V. Mouthpiece
US10087225B2 (en) 2015-01-08 2018-10-02 Moerae Matrix, Inc. Formulation of MK2 inhibitor peptides
CA2974661A1 (fr) 2015-01-21 2016-07-28 Mylan Inc. Systeme d'emballage de medicament et de regime posologique
US20160264658A1 (en) 2015-03-11 2016-09-15 Glaxosmithkline Intellectual Property Development Limited TSLP Binding Proteins
EP3268022A4 (fr) 2015-03-12 2018-11-21 Moerae Matrix, Inc., Utilisation de compositions contenant un peptide inhibiteur de mk2 pour traiter un cancer du poumon non à petites cellules avec celles-ci
WO2016187695A1 (fr) * 2015-05-22 2016-12-01 Compressed Perforated Puck Technologies Inc. Appareil vaporisateur pour comprimé compressé et matériaux source végétaux en vrac
CA2987071A1 (fr) 2015-06-10 2016-12-15 Hackensack University Medical Center Utilisation du telmisartan pour la prevention et le traitement de la maladie du greffon contre l'hote et d'autres maladies auto-immunes et allo-immunes
US20180179167A1 (en) 2015-06-15 2018-06-28 Glaxosmithkline Intellectual Property Development Limited Nrf2 REGULATORS
ES2910938T3 (es) 2015-06-15 2022-05-17 Glaxosmithkline Ip Dev Ltd Reguladores de NRF2
SI3782996T1 (sl) 2015-06-15 2024-06-28 Glaxosmithkline Intellectual Property Development Limited Nrf2 regulatorji
CN107949279A (zh) 2015-07-06 2018-04-20 得克萨斯系统大学评议会 可用作用于治疗人类癌症的抗癌剂的苯甲酰胺或苯扎明化合物
DK3322417T3 (da) 2015-07-15 2023-10-30 Univ Texas Målretning af emopamil-bindingsprotein (EBP) med små molekyler, der inducerer et unormalt feedbackrespons ved sænkning af endogen cholesterolsyntese
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
WO2017060854A1 (fr) 2015-10-06 2017-04-13 Glaxosmithkline Intellectual Property Development Limited Biaryl pyrazoles utilisés comme régulateurs de nrf2
WO2017060855A1 (fr) 2015-10-06 2017-04-13 Glaxosmithkline Intellectual Property Development Limited Pyrazoles d'arylcyclohéxyle utilisés en tant que régulateurs de nrf2
AU2016357651A1 (en) 2015-11-18 2018-05-17 Glaxosmithkline Intellectual Property (No.2) Limited Pharmaceutical compositions of ribavirin
WO2017127641A1 (fr) 2016-01-20 2017-07-27 Flurry Powders Encapsulation d'ingrédients lipophiles dans des poudres séchées par pulvérisation pouvant être dispersées destinées à l'inhalation
US11833118B2 (en) 2016-01-20 2023-12-05 Flurry Powders, Llc Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
JP6957520B2 (ja) 2016-05-19 2021-11-02 トゥルーデル メディカル インターナショナル スマート弁付き保持チャンバ
US10786638B2 (en) 2016-07-08 2020-09-29 Trudell Medical International Nebulizer apparatus and method
EP3984579B1 (fr) 2016-07-08 2024-09-04 Trudell Medical International Inc. Dispositif intelligent à pression expiratoire positive oscillante
CN109790116B (zh) 2016-09-20 2022-10-28 葛兰素史密斯克莱知识产权（第2 号）有限公司 Trpv4拮抗剂
JP2019532054A (ja) 2016-09-20 2019-11-07 グラクソスミスクライン、インテレクチュアル、プロパティー、（ナンバー２）、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ （Ｎｏ．２） Ｌｉｍｉｔｅｄ Ｔｒｐｖ４拮抗薬
TW201825458A (zh) 2016-09-20 2018-07-16 英商葛蘭素史克智慧財產（第二）有限公司 Ｔｒｐｖ４拮抗劑
WO2018104766A1 (fr) 2016-12-06 2018-06-14 Glaxosmithkline Intellectual Property Development Limited Dérivés d'acide propanoïque 3-(2,3-dihydro-1h-inden-5-yl) et leur utilisation en tant que régulateurs de nrf2
WO2018104805A1 (fr) 2016-12-09 2018-06-14 Trudell Medical International Nébuliseur intelligent
JP2020500918A (ja) 2016-12-12 2020-01-16 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ Ｎｒｆ２レギュレーターとしてのｎ−アリールピラゾール
US20200031820A1 (en) 2016-12-12 2020-01-30 Glsxosmithkline Intellectual Property Development Limited 3-carboxylic acid pyrroles as nrf2 regulators
US11078216B2 (en) 2016-12-14 2021-08-03 Glaxosmithkline Intellectual Property Development Limited Bisaryl amides as NRF2 activators
WO2018109648A1 (fr) 2016-12-14 2018-06-21 Glaxosmithkline Intellectual Property Development Limited Composés de 3-oxo-1,4-diazépinyle en tant qu'activateurs de nrf2
EP3555078B1 (fr) 2016-12-14 2024-03-27 GlaxoSmithKline Intellectual Property Development Limited Hétérocycles bisaryles en tant qu' activateurs nrf2
ES2908941T3 (es) 2016-12-15 2022-05-04 Glaxosmithkline Ip Dev Ltd Triazoles unidos a éter como reguladores de NRF2
ES2901616T3 (es) 2016-12-15 2022-03-23 Glaxosmithkline Ip Dev Ltd Compuestos NRF2
CN108328122B (zh) * 2017-01-17 2024-04-12 李和伟 一种制剂盒
CA3059449A1 (fr) 2017-04-24 2018-11-01 Cocrystal Pharma, Inc. Derives de pyrrolopyrimidine utiles en tant qu'inhibiteurs de la replication du virus de la grippe
WO2019116231A1 (fr) 2017-12-11 2019-06-20 Glaxosmithkline Intellectual Property Development Limited Activateur de nrf2 pour le traitement d'une lésion pulmonaire aiguë, d'un syndrome de détresse respiratoire aiguë et d'un syndrome de dysfonction d'organes multiples
US20210177861A1 (en) 2017-12-11 2021-06-17 Glaxosmithkline Intellectual Property Development Limited Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
GB201720989D0 (en) 2017-12-15 2018-01-31 Glaxosmithkline Ip Dev Ltd Chemical compounds
CA3086890A1 (fr) 2018-01-04 2019-07-11 Trudell Medical International Dispositif intelligent a pression expiratoire positive oscillante
CN111868063B (zh) 2018-01-17 2023-08-01 葛兰素史克知识产权开发有限公司 PI4KIIIβ抑制剂
CN108815653B (zh) * 2018-04-19 2020-11-10 山西白求恩医院 一种气体速度可调节的雾化器
US11643407B2 (en) 2018-05-23 2023-05-09 Glaxosmithkline Intellectual Property Development Limited Indanes as NRF2 activators
US20210121462A1 (en) 2018-07-27 2021-04-29 Cocrystal Pharma, Inc. Pyrrolo[2,3-b]pyridin derivatives as inhibitors of influenza virus replication
GB201812671D0 (en) 2018-08-03 2018-09-19 Coalesce Product Dev Ltd An inhaler device
TWI844564B (zh) 2018-09-10 2024-06-11 美商共結晶製藥公司 流感病毒複製之抑制劑
PL3866778T3 (pl) 2018-10-17 2023-03-27 Cocrystal Pharma, Inc. Kombinacje inhibitorów replikacji wirusa grypy
EP3880251A1 (fr) 2018-11-13 2021-09-22 Cocrystal Pharma, Inc. Formulations d'agents thérapeutiques contre la grippe
WO2020112716A1 (fr) 2018-11-26 2020-06-04 Cocrystal Pharma, Inc. Inhibiteurs de la réplication du virus de la grippe
WO2020135920A1 (fr) * 2018-12-28 2020-07-02 Université Libre de Bruxelles Kit pour chimiothérapie inhalée et traitement du cancer du poumon à l'aide dudit kit
DE102019134285A1 (de) 2019-01-15 2020-07-16 Nuuvera Deutschland GmbH Vorrichtung und Verfahren zum Extrahieren und Aspirieren von Wirkstoffen, insbesondere aus der Cannabispflanze
CN109939309B (zh) * 2019-04-01 2021-06-01 中国科学院大学深圳医院(光明) 粉状物吸入装置
GB201908536D0 (en) 2019-06-13 2019-07-31 Glaxosmithkline Ip Dev Ltd Compounds
US11712175B2 (en) 2019-08-27 2023-08-01 Trudell Medical International Smart oscillating positive expiratory pressure device with feedback indicia
US20230151034A1 (en) 2020-03-17 2023-05-18 Cocrystal Pharma, Inc. Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication
EP4132944A1 (fr) 2020-04-10 2023-02-15 Cocrystal Pharma, Inc. Inhibiteurs de la réplication de norovirus et de coronavirus
EP4138884A1 (fr) 2020-04-20 2023-03-01 Sorrento Therapeutics, Inc. Administration pulmonaire de polypeptides ace2
CN112298819A (zh) * 2020-10-28 2021-02-02 朱爱庆 一种具有防潮功能的定量取药瓶
WO2022175425A1 (fr) 2021-02-22 2022-08-25 Glaxosmithkline Intellectual Property Development Limited Inhibiteurs de la kinase mtor inhalés destinés à être utilisés dans le traitement ou la prévention d'une infection par un virus respiratoire à arn
WO2022179967A1 (fr) 2021-02-23 2022-09-01 Glaxosmithkline Intellectual Property (No.2) Limited Vadadustat pour le traitement de la covid-19 chez un sujet hospitalisé
EP4323039A4 (fr) 2021-04-14 2025-04-02 Univ North Carolina Chapel Hill Systèmes de dosage solides poreux chauds et procédés de génération d'aérosols thérapeutiques par évaporation/condensation
US20240398757A1 (en) 2021-08-03 2024-12-05 Cocrystal Pharma, Inc. Inhibitors for coronaviruses
US11517704B1 (en) * 2021-12-06 2022-12-06 Stat Capsule Inc. Wristband capsule crusher
CN114098624B (zh) * 2021-12-30 2022-09-02 山东第一医科大学附属省立医院(山东省立医院) 一种可视的直肠快速内检装置

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB516834A (en) * 1937-12-23 1940-01-12 Charles Alexandre Nicolle Improvements in or relating to packaging
CH385718A (fr) * 1961-11-04 1964-12-15 Bodet Jean Procédé et dispositif pour conditionner des articles solides de petit volume, et ensemble obtenu par ce procédé
CH411232A (de) * 1963-11-12 1966-04-15 Ciba Geigy Arzneimittelverpackung
GB1268051A (en) * 1968-06-07 1972-03-22 Fisons Pharmaceuticals Ltd Inhalation device
DE2321615A1 (de) * 1973-04-28 1974-11-14 Aluminium Walzwerke Singen Kindersichere verpackung
GB1387954A (en) * 1973-05-08 1975-03-19 Miles Lab Insufflator
US4015717A (en) * 1974-03-29 1977-04-05 The Medical Dispenser Company Tablet package for use in chronologically dispensing tablets
YU41046B (en) * 1974-08-22 1986-10-31 Schering Ag Medicine inholating device
AT337088B (de) * 1975-05-20 1977-06-10 Desinfecta Ges M B H Verpackung fur pulver, korner und dgl. und verfahren zu ihrer herstellung
GB1562732A (en) * 1976-02-10 1980-03-12 Allen & Hanburys Ltd Device for dispensing medicaments
DE2716323C2 (de) * 1977-04-07 1986-03-13 Schering AG, 1000 Berlin und 4709 Bergkamen Vorrichtung zur Inhalation von Arzneimitteln
DE2835122C3 (de) * 1978-08-10 1982-02-18 Bosch-Siemens Hausgeräte GmbH, 7000 Stuttgart Inhalationsgerät
GB2061735B (en) * 1979-10-30 1983-11-30 Riker Laboratories Inc Breath actuated device for administration of powdered medicaments by inhalation
BR8007911A (pt) * 1979-12-06 1981-06-16 Glaxo Group Ltd Inalador aperfeicoado
GB2064336B (en) * 1979-12-06 1984-03-14 Glaxo Group Ltd Device for dispensing medicaments
US4307734A (en) * 1980-06-23 1981-12-29 B & B Inventors & Marketers, Inc. Snuff dispenser
ES8206980A1 (es) * 1980-10-30 1982-09-01 Riker Laboratories Inc Un dispositivo para facilitar la inhalacion oral de medica- mentos en forma de polvo
DE8218231U1 (de) * 1982-06-25 1982-12-30 Karl Knauer Gmbh & Co Kg, 7616 Biberach Schaupackung insbesondere Blisterpackung

Also Published As

Publication number Publication date
GR79615B (fr) 1984-10-31
SE8305542L (sv) 1984-04-09
AT396333B (de) 1993-08-25
ES286422Y (es) 1986-09-16
PT77471A (en) 1983-11-01
DE3336486A1 (de) 1984-04-26
JPH0620532Y2 (ja) 1994-06-01
FI79651C (fi) 1990-02-12
FR2570607A1 (fr) 1986-03-28
CY1478A (en) 1989-07-21
AU1997783A (en) 1984-04-12
IL69932A0 (en) 1984-01-31
NO160330B (no) 1989-01-02
IE56059B1 (en) 1991-04-10
AU8315587A (en) 1988-04-21
IE832367L (en) 1984-04-08
KR910002248B1 (ko) 1991-04-08
FR2550452A1 (fr) 1985-02-15
CY1477A (en) 1989-07-21
IT8349120A0 (it) 1983-10-07
NL192564B (nl) 1997-06-02
NO160330C (no) 1989-04-12
ATA357683A (de) 1992-12-15
DK172541B1 (da) 1998-12-07
KR840006441A (ko) 1984-11-30
DE3336486C2 (fr) 1990-10-04
FI833641L (fi) 1984-04-09
SE8305542D0 (sv) 1983-10-07
SE465752B (sv) 1991-10-28
ES286422U (es) 1986-02-01
BR8305562A (pt) 1984-05-15
CA1224992A (fr) 1987-08-04
LU85034A1 (fr) 1985-06-19
FI79651B (fi) 1989-10-31
NZ205892A (en) 1987-07-31
CH662277A5 (de) 1987-09-30
SE458824B (sv) 1989-05-16
IN160851B (fr) 1987-08-08
SE8803702L (sv) 1988-10-17
US4627432A (en) 1986-12-09
IT1203660B (it) 1989-02-15
PT77471B (en) 1986-08-19
ZW21483A1 (en) 1985-05-08
SG6889G (en) 1989-06-09
HK67789A (en) 1989-09-01
JPH0576872B2 (fr) 1993-10-25
GB2129691B (en) 1987-08-05
AU570013B2 (en) 1988-03-03
SE8803702D0 (sv) 1988-10-17
JPH04131250U (ja) 1992-12-02
FR2550452B1 (fr) 1992-05-22
FI833641A0 (fi) 1983-10-07
FR2570607B1 (fr) 1992-04-10
NL192564C (nl) 1997-10-03
DK464383D0 (da) 1983-10-07
NO833667L (no) 1984-04-09
NL8303461A (nl) 1984-05-01
DK464383A (da) 1984-04-09
GB8326878D0 (en) 1983-11-09
GB2129691A (en) 1984-05-23
IL69932A (en) 1987-12-31
JPH05200100A (ja) 1993-08-10
AU584535B2 (en) 1989-05-25

Similar Documents

Publication Publication Date Title
GB2129691B (en) Devices for administering medicaments to patients
GB8602264D0 (en) Administering medicaments to patients
GB2178965B (en) Devices for administering medicaments to patients
DE3166709D1 (en) Inhalation device for administering medicaments
ZA82124B (en) Bandage for administering beneficial drug
GB2184016B (en) Therapeutic device for the administration of medicaments
DE3372066D1 (en) Pharmaceutical preparation for endermic use
ZA81706B (en) Device for the administration of medicaments
ZA837318B (en) Device for administering medicaments to patients
DE3367734D1 (en) Apparatus for administering a liquid to patients
ZA865655B (en) Devices for administering medicaments to patients
ZA833721B (en) Administering fluid to patients
GB8525067D0 (en) Administering medicaments to patients
RO81783A3 (fr) Medicament pour le traitement de la maladie neoplastique
KR850002630Y1 (en) Device for administering medicine orally
ZA812634B (en) Breath actuated devices for administering powered medicaments
GB8316632D0 (en) Administering medicaments
GB8315106D0 (en) Dose administering device